Blood Cancer Journal (Mar 2024)

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

Ayalew Tefferi,
Animesh Pardanani

Affiliations

Ayalew Tefferi: Division of Hematology, Department of Medicine, Mayo Clinic
Animesh Pardanani: Division of Hematology, Department of Medicine, Mayo Clinic

DOI: https://doi.org/10.1038/s41408-024-01029-3
Journal volume & issue: Vol. 14, no. 1
pp. 1 – 3

Abstract

No abstracts available.

Published in Blood Cancer Journal

ISSN: 2044-5385 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.nature.com/bcj/index.html

About the journal